No Data
Jieya Co., Ltd. (301108.SZ) plans to establish a subsidiary in the USA and invest in the construction of a wet wipe production base.
On December 27, Gelonghui reported that Jieya Co., Ltd. (301108.SZ) announced that based on the current international trade situation, changes in the Global supply chain, and future Business development plans, it intends to establish a wholly-owned subsidiary, Joyalways Corporation (tentatively named "USA subsidiary", final name subject to local approval), through its wholly-owned USA subsidiary, Joyalways Investment Corporation, and invest in the construction of a wet wipes production base. The total investment for the project is预计约0.616 billion RMB (approximately 85 million USD).
Tongling Jieya Biologic Technology Co., Ltd.'s (SZSE:301108) Business Is Trailing The Market But Its Shares Aren't
Jieya Co., Ltd. (301108.SZ): plans to permanently use 0.19 billion yuan of oversubscribed funds to supplement working capital.
On December 9th, Gelonghui announced that Jieya Co., Ltd. (301108.SZ) held the 22nd meeting of the fifth board of directors and the 20th meeting of the fifth board of supervisors on December 9, 2024, respectively reviewing and approving the proposal regarding the permanent supplementation of working capital using part of the oversubscribed funds, agreeing to use 0.19 billion yuan of oversubscribed funds to permanently supplement working capital. This proposal still needs to be submitted for approval at the company's shareholder meeting.
Jieya Co., Ltd. (301108.SZ): Invested in the establishment of a wholly-owned subsidiary in the usa and completed the business registration.
On November 21, Gelonghui reported that Jeya Co., Ltd. (301108.SZ) announced the establishment of a wholly-owned subsidiary, Joyalways Investment Corporation (hereinafter referred to as "USA Subsidiary"), in Delaware, USA, with its own funds to meet the business development needs of the company, deepen cooperation with overseas customers, and improve the stability and efficiency of the international supply chain, in line with the company's actual situation. The main business of the USA Subsidiary will be to engage in import and export trade and serve as an investment platform for overseas investment activities. Recently, the company received the registration certificate for the USA Subsidiary.
Tongling Jieya Biologic Technology's (SZSE:301108) Anemic Earnings Might Be Worse Than You Think
Clean Elegant Co., Ltd. (301108.SZ): The main growth points of future profits mainly depend on the expansion of existing business and new product categories for existing customers.
Gelonghui, October 31 - Jiaya Stock (301108.SZ) received a specific research inquiry on October 31, 2024, regarding "What are the future profit growth points of the company?" The company stated that it mainly relies on expanding the existing customer base and developing new product categories. With the introduction of the EU's plastic limit policy, some international brands are relocating their supply chains, and the company is actively engaging in discussions to undertake relevant business.
Returns On Capital Signal Tricky Times Ahead For Tongling Jieya Biologic Technology (SZSE:301108)See the daily top gainer.
